| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 573.89K | — |
| Operating expense | — | — |
| Net income | -433.68K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XBIO returned +18.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +65.4% |
| 1 year | +18.5% |
| 5 years | -88.0% |
| 10 years | -99.4% |
| All-time high | $612.00 (Jun 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in XBIO would be worth today ›No. Xenetic Biosciences, Inc. has not paid a dividend in the past 12 months.
Xenetic Biosciences, Inc. stock trades on NASDAQ under the ticker symbol XBIO.
Xenetic Biosciences, Inc. is part of the Healthcare sector.
Xenetic Biosciences, Inc. has a market cap of 8.41M USD, based on the latest quote.
